Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel GSK-3 inhibitors and their use in diabetes, neurodegeneration, etc.

Aug. 9, 2002

AstraZeneca to provide additional information for Crestor approval

Aug. 9, 2002

HE-2200 cleared to enter phase II in patients with elevated cholesterol

Aug. 9, 2002

Sangart reports positive data for Hemospan

Aug. 8, 2002

Osteoprotegerin deficiency described as a possible cause of juvenile Paget's disease

Aug. 8, 2002

Novel NPY5 modulators in early development at Neurogen

Aug. 7, 2002

Merck & Co. researchers identify new alphavbeta3/alphavbeta5 integrin antagonists

Aug. 7, 2002

Rats expressing DPP-IV show improved glycemic control after treatment with NVP-DPP-728

Aug. 7, 2002

Bayer claims novel beta3-adrenoceptor agonists for diabetes, obesity, etc.

Aug. 6, 2002

Akzo Nobel researchers identify new androgenic/progestagenic compounds

Aug. 6, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...